5-Amino-1MQ in Canada
5-Amino-1MQ is 5-amino-1-methylquinolinium iodide, a small salt rather than a peptide. University of Texas labs reported it in 2017 as a blocker of NNMT, a methyl-tagging enzyme. Its research is in cells and mice, and no NNMT blocker has reached human trials. It isn't approved anywhere as a drug.

Pack prices and discount codes don't combine. You always get the bigger saving.
In stock · ships same-day with ice pack
Sold for laboratory research use only. Not for human or veterinary use. 19+.
- First reported, by University of Texas labs
- 2017
- Amino acids, so it isn't a peptide
- 0
- Molar mass, as the iodide salt
- 286.11g/mol
- Human trials of any NNMT blocker
- 0
- Approved as a drug
- Nowhere
- Free over $250 Shipping $20 to $25 under that
- Interac e-Transfer Confirms in ~30 min
- 14-day returns Free return shipping
- Third-party tested Janoshik Analytical results below
- Ships cold Paid by noon, ships same day
- Mixing calculator Get your volumes
What is 5-Amino-1MQ?
The plain-language version, first.
5-Amino-1MQ is a small charged molecule with two fused rings and no amino acids, built to block an enzyme called NNMT.
Second entry in what is becoming an accidental series: things in the peptide aisle that are not peptides.
No amino acids. No peptide bonds. A cation mass of 159.21, which next to a 39-residue molecule is a rounding error.
It is a small molecule. It got shelved here because of who buys it, not because of what it is.
What it does have is a specific target, and the target is genuinely worth knowing about: an enzyme called NNMT.
NNMT sits in a metabolic pathway involving methyl groups, and interest in it comes from the enzyme's own biology rather than from anything this particular inhibitor has demonstrated.
A well-motivated target with a compound attached. Those are two separate quality judgements and people keep collapsing them into one.
What is 5-Amino-1MQ?
What researchers watch it do.
It blocks an enzyme most people have never heard of, and that enzyme is the interesting part.
Right, methyl groups. Stay with me, because this bit is actually neat.
Your cells move small chemical tags around constantly, and a methyl group is one of the most common. Attaching one changes what a molecule does, or where it goes, or how fast it gets cleared.
NNMT is an enzyme that attaches methyl groups to a specific target. Block the enzyme, and the traffic in that lane changes.
That is the entire logic and it is a reasonable one. It is the same logic behind a large amount of legitimate drug discovery.
What makes this compound specifically interesting to a laboratory is that it is a usable tool for asking what NNMT does when it is turned down.
Here's the honest part. Tool compound is a real and respectable category, and it is not the same category as a clinical candidate.
Being useful for asking a question is different from being an answer.
What does the research say about 5-Amino-1MQ?
What the studies found, and where they stand.
Good target biology. Thin compound biology. Do not confuse the two.
The target literature and the compound literature are two different sizes and it matters which one somebody is quoting at you.
NNMT itself has a real and growing body of work. Metabolic researchers find it genuinely interesting and that interest is not manufactured.
This inhibitor has considerably less behind it, and almost all of it is preclinical.
That gap is where most of the confident writing about this compound lives. Somebody reads an enthusiastic paper about the enzyme and attributes the enthusiasm to the molecule.
No human trials. Nothing approved. A target worth watching and a compound that has not yet earned the attention its target is getting.
Interesting enzyme. Unfinished molecule. Both true, and the second one is what is in the vial.
Stock and vial sizes are listed just below.
What did the lab find in our 5-Amino-1MQ?
2 sizes, one lot each, the lab's numbers for every one.
5 mgLot 2218-58898.28%5.22 mgOpenClose
10 mgLot 2287-12798.47%10.39 mgOpenClose
What's in a vial of 5-Amino-1MQ?
The chemistry, exactly as released.
Who studies 5-Amino-1MQ?
Who tends to order this one, and why.
- 1
NAD+ metabolism
The cleanest available contrast with NMN and NR. Same endpoint, opposite end of the pathway, and one additional consequence in SAM that the substrate approach does not touch.
- 2
Methyltransferase pharmacology
A selectivity panel across DNMT1, PRMT3, COMT, NAMPT and SIRT1 makes it a useful reference point for what a selective methyltransferase inhibitor looks like.
- 3
Adipocyte biology
Most of the mechanistic work was done in differentiated 3T3-L1 adipocytes, measuring 1-methylnicotinamide, NAD+, SAM and lipogenesis directly.
- 4
Small molecules in a peptide market
A case study in how distribution channel rather than chemistry determines what gets marketed together.
Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.
Where did 5-Amino-1MQ come from?
How it got here.
The molecule is a copy of the enzyme’s own product, and that is not a coincidence.
Quinoline is an NNMT substrate. The enzyme methylates it into 1-methylquinolinium, and 1-methylquinolinium is fluorescent. In 2017 Watowich’s lab at UTMB Galveston built the first real-time fluorescent NNMT assay around exactly that fact, reading out the quinolinium directly. Having spent months watching the product accumulate, they turned it into the starting point for an inhibitor series, and the chemistry moved to Stanton McHardy’s group at UT San Antonio.
The SAR paper landed in the Journal of Medicinal Chemistry in June 2017, where the compound is a numbered entry in a table rather than a named product. The name 5-amino-1MQ enters the literature later that year in Biochemical Pharmacology, where it stops being one row in a table and becomes the lead compound.
There is a neat symmetry underneath all of this. NNMT is inhibited by its own product: 1-methylnicotinamide has a measured IC50 of 9.0 micromolar against the enzyme that makes it.
- 1
The assay came before the drug
NNMT methylates quinoline into a fluorescent product. The Galveston lab built its enzyme assay around detecting that product, then turned the product into the inhibitor.
- 2
Two Texas campuses
Biology at UT Medical Branch in Galveston under Stephan Watowich, chemistry at UT San Antonio under Stanton McHardy. The patent belongs to the UT System.
- 3
Not Scripps
Scripps Research does appear in NNMT inhibitor history, in La Jolla and on a covalent chemotype, but that work is separate and its conclusions were cautionary. This compound is not theirs.
How do I buy 5-Amino-1MQ in Canada?
What ships, how fast, and the paperwork.
Two different masses, both correct. The cation is 159.21 and the iodide salt is 286.11. Roughly 55.6 percent of the solid mass is the cation. The original mouse work dose-corrected for this explicitly, so any figure quoted without stating which mass it refers to is ambiguous.
Not a peptide, and not a supplement. It is a synthetic quaternary quinolinium salt, so it does not meet the statutory definition of a dietary ingredient, and no new dietary ingredient notification was found for it. It has no DIN or NPN in Canada.
Store cool, dry and dark. A crystalline salt rather than a lyophilised peptide, but the same handling logic applies. Treat as a laboratory reagent.
What else do people ask?
5 answers, none of them dodges.
Is 5-Amino-1MQ a peptide?
No. It is a synthetic quaternary quinolinium salt: a single fused bicyclic aromatic ring with a permanently charged nitrogen, twelve heavy atoms, no amide bonds and no amino acid residues. Peptides are amino acids joined by amide bonds. It is sold alongside peptides because it shares a distribution channel and a customer, not because of any structural or pharmacological relationship.
How is it different from NMN or NR?
All three can raise NAD+, but from opposite ends of the pathway. NMN and NR are substrates that feed into the salvage pathway from the front. 5-Amino-1MQ is an inhibitor that blocks the exit, stopping NNMT from methylating nicotinamide into a form the body excretes. There is also a consequence with no NMN or NR equivalent: every NNMT reaction consumes a molecule of SAM, so blocking the enzyme spares the cell’s methyl donor pool. No published study compares them head to head in any species.
Are there human clinical trials?
None. Searches of ClinicalTrials.gov for 5-amino-1MQ, 5-amino-1-methylquinolinium, methylquinolinium and NNMT inhibitor return zero interventional studies. No NNMT inhibitor of any chemotype has reached human trials. A 2026 review in Trends in Pharmacological Sciences describes clinical translation for the class as an emerging prospect rather than an achieved one. There is no published human pharmacokinetic, safety or dose-finding data.
Where did it come from?
The University of Texas. Stephan Watowich’s lab at UT Medical Branch in Galveston built a fluorescent NNMT assay in early 2017 based on the enzyme methylating quinoline into fluorescent 1-methylquinolinium. Stanton McHardy’s chemistry group at UT San Antonio then developed a quinolinium inhibitor series from that scaffold, published in the Journal of Medicinal Chemistry in June 2017. The patent is held by the UT System.
How potent is it?
IC50 of 1.2 micromolar against recombinant human NNMT, and a cellular EC50 of 2.3 micromolar measured in differentiated adipocytes. For context, bisubstrate NNMT inhibitors published since are orders of magnitude more potent. No Ki has been published, so any quoted Ki value is unsourced.
What pairs well with 5-Amino-1MQ?
What researchers stack alongside it.
Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as 5-Amino-1MQ, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

Your cells' batteries text head office when fuel runs low, and this is the text. Lab research has looked at it for fuel use and endurance.

A four-building-block lab-made protein that heads straight for your mitochondria, the power plants in your cells. It parks on the fat that holds their machinery in place, like a regular on his favourite barstool, and the FDA approved it in 2025 for a rare disease where those power plants fail.
Supplies for the lab
What else is in Metabolic?
Other compounds in the same research category.
Ready to order 5-Amino-1MQ?
One last look before you decide.
Freeze-dried, lab results on the page, ships cold
You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, 5-Amino-1MQ is right here.
Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.
Page last updated October 13, 2026. Reviewed by the Pro Peptide team.
What do people search for with 5-Amino-1MQ?
Related searches.

